Today, the CFO of Medidata Solutions (NASDAQ: MDSO), Rouven Bergmann, sold shares of MDSO for $226.6K.
See today’s analyst top recommended stocks >>
Based on Medidata Solutions’ latest earnings report for the quarter ending March 31, the company posted quarterly revenue of $149 million and quarterly net profit of $10.33 million. In comparison, last year the company earned revenue of $127 million and had a net profit of $9.52 million. MDSO’s market cap is $4.47B and the company has a P/E ratio of 100.71. Currently, Medidata Solutions has an average volume of 578.1K.
Based on 5 analyst ratings, the analyst consensus is Strong Buy with an average price target of $86.60, reflecting a -12.0% downside.
The insider sentiment on Medidata Solutions has been negative according to 53 insider trades in the past three months. This sentiment is lower than the average sentiment of company insiders in this sector.
Company insider trades’ information is brought to you by the DailyInsider, a proprietary algorithm that analyzes insider trading activity to detect the most attractive trading opportunities. To subscribe to the DailyInsider visit this page.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
Medidata Solutions, Inc. provides cloud based solutions for life sciences that enhance the efficiency of customer’s clinical development processes from concept to conclusion, optimizing their research and development investments.
